RxDoctor Payments Data

Charles Phillips, MD

Family Medicine · Newport News, VANPI 1821089905

Payments from drug & device makers

$8,778in general payments, 2019–2025

Across 543 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$884
  • AstraZeneca$742
  • Lilly USA, LLC$624
  • GSK$505
  • Pfizer$469
  • plus $5K from 49 others

What the payments were for

  • Food & beverage$8,764100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)72$1,012
Novo Nordisk56$884
AstraZeneca47$742
Lilly USA, LLC43$624
GSK30$505
Pfizer30$469
Amgen(2 entities)29$450
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$393
Takeda Pharmaceuticals U.S.A., Inc.23$367
Boehringer Ingelheim19$344
Amarin Pharma, Inc.20$333
Abbott6$210
Merck12$186
Teva Pharmaceuticals USA, Inc.9$168
Biohaven Pharmaceuticals, Inc.9$159
Johnson & Johnson10$153
Clarus Therapeutics Inc.11$137
Antares Pharma, Inc.7$133
Sanofi-aventis U.S. LLC7$113
Exact Sciences5$100
Astellas Pharma US Inc5$98
Arbor Pharmaceuticals, Inc.5$97
Mylan Specialty L.p.6$76
Gilead4$74
Tolmar, Inc.4$73
Paratek Pharmaceuticals, Inc.3$55
Jazz Pharmaceuticals Inc.3$52
Neos Therapeutics, LP3$48
Upsher-smith Laboratories LLC2$47
Biohaven Pharmaceutical Holding Company Ltd.2$46
Shire North American Group Inc3$46
Axsome Therapeutics, Inc.2$44
Kowa Pharmaceuticals America, Inc.3$42
Esperion Therapeutics, Inc.2$40
E.r. Squibb & Sons, L.L.C.2$36
Amneal Pharmaceuticals LLC2$35
Kaleo, Inc.2$33
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$32
Nestle Healthcare Nutrition Inc.2$30
Acella Pharmaceuticals, LLC1$27
Aytu Biopharma, Inc.2$25
Novartis1$23
Otsuka America Pharmaceutical, Inc.1$23
Azurity Pharmaceuticals, Inc.1$20
Almatica Pharma LLC1$20
Philips North America LLC1$18
Shield Therapeutics Inc1$18
Bausch Health US, LLC1$17
Sumitomo Pharma America, Inc.1$17
Phadia US Inc.1$16
Xeris Pharmaceuticals, Inc.1$14
Lupin Inc.1$14
Genentech USA, Inc.1$14
Ironshore Pharmaceuticals Inc.1$12
Metuchen Pharmaceuticals1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,778 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$313,599
Medicare patients
662
Services billed
7,815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$169,558
EliquisApixaban53$53,915
TrulicityDulaglutide34$36,932
JanuviaSitagliptin Phosphate31$32,288
Tresiba Flextouch U-200Insulin Degludec24$29,739
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog62$27,550
JardianceEmpagliflozin26$26,399
XareltoRivaroxaban17$21,132
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$20,707
MyrbetriqMirabegron22$19,032
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$10,759
Tresiba Flextouch U-100Insulin Degludec13$7,508
SymbicortBudesonide/Formoterol Fumarate14$5,230
Albuterol Sulfate HfaAlbuterol Sulfate151$4,793
SynthroidLevothyroxine Sodium105$4,560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$884$169,558110 claims
PfizerEliquis$469$53,91553 claims
Lilly USA, LLCTrulicity$624$36,93234 claims
MerckJanuvia$186$32,28831 claims
Boehringer IngelheimJardiance$344$26,39926 claims
Johnson & JohnsonXarelto$153$21,13217 claims
GSKTrelegy Ellipta$505$20,70716 claims
Astellas Pharma US IncMyrbetriq$98$19,03222 claims
AstraZenecaSymbicort$742$5,23014 claims
AbbVieSynthroid$1,012$4,560105 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$35$3,942416 claims
Sanofi-aventis U.S. LLCLantus$113$2,67130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →